Differences in the treatment and control of hypertension in urban and rural residents of the northeastern region of the People’s Republic of China: a cross-sectional study

References

• World Health Organization. Ten years in public health, 2007–2017: report by Dr Margaret Chan, Director-General, World Health Organization. Geneva, Switzerland: World Health Organization; 2017.
   Google Scholar
• World Health Organization. New WHO data portal to help track progress towards universal health coverage. Media centre, News release. Geneva, Switzerland: World Health Organization; 2016.
   Google Scholar
• Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.
   PubMed Web of Science ®Google Scholar
• Mittal BV, Singh AK. Hypertension in the developing world: Challenges and opportunities. Am J Kidney Dis. 2010;55:590–98.
   PubMed Web of Science ®Google Scholar
• Turnbull F, Neal B, Algert C, Chalmers J, Woodward M, MacMahon S, MacMahon S, Baigent C, Cutler J, Fagard R, et al. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362: 1527–1535.
   PubMed Web of Science ®Google Scholar
• Neal B, MacMahon S, Chapman N, Cutler J, Fagard R, Neal B, Whelton P, Yusuf S, Agodoa L, Baigent C, et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 356: 1955–1964.
   PubMed Web of Science ®Google Scholar
• Miura K, Nagai M, Ohkubo T. Epidemiology of hypertension in Japan - Where are we now? -. Circ J. 2013;77:2226–31.
   PubMed Web of Science ®Google Scholar
• Hales CM, Carroll MD, Simon PA, Kuo T, Ogden CL. Hypertension prevalence, awareness, treatment, and control among adults aged ≥ 18 years - los angeles county, 1999-2006 and 2007-2014. Mmwr-Morbid Mortal W. 2017;66:846–49.
   PubMed Web of Science ®Google Scholar
• Ikeda N, Sapienza D, Guerrero R, Aekplakorn W, Naghavi M, Mokdad AH, Lozano R, Murray CJ, Lim SS. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. B World Health Organ. 2014;92:10–19.
   PubMed Web of Science ®Google Scholar
• Egan BM, Zhao YM, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. Jama-J Am Med Assoc. 2010;303:2043–50.
   PubMed Web of Science ®Google Scholar
• Palafox B, Stuckler D, Balabanova D, Yusuf S, McKee M. Wealth-related inequalities in the awareness, treatment and control of hypertension in 21 countries. Eur J Public Health 2016; 26: 120–121
   Web of Science ®Google Scholar
• Liu P, Lv J, Liu FC, Li DJ, Hao M. Prevalence, awareness, treatment, and control of hypertension in high-, middle-, and low-income provinces of China. Cardiology 2014; 129: 15–15.
   Web of Science ®Google Scholar
• Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global Disparities of Hypertension Prevalence and Control A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation 2016; 134: 441–450.
   PubMed Web of Science ®Google Scholar
• Wang JN, Sun W, George A.W, Li ZB, Li TY, Wu JD, Zhang YY, Liu YY, Li LB, Yu YP, et al. Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People’s Republic of China: a cross-sectional study. Plos one 2018;13: e0195340.
   PubMed Web of Science ®Google Scholar
• Wu J, Li T, Song X, Sun W, Zhang Y, Liu Y, Li L, Yu Y, Liu Y, Qi C, et al. Prevalence and distribution of hypertension and related risk factors in Jilin Province, China 2015: a cross-sectional study. BMJ Open. 2018;8:e020126.
   PubMedGoogle Scholar
• Chinese Committee for the Prevention and Treatment of Hypertension. Guidelines for prevention and treatment of hypertension in China 2010. Journal Chin Hypertens. 2011;19:701–43.
   Google Scholar
• The sixth census leading group office of Jilin Province, Jilin provincial bureau of statistics. Jilin Province 2010 census data. Beijing: China Statistics Press; 2012. 461–72.
   Google Scholar
• Li W, Gu HQ, Teo KK, Bo J, Wang Y, Yang J, Wang X, Zhang H, Sun Y, Jia X, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47000 people from China. J Hypertens. 2016;34:39–46.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, et al. Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association. Circulation 2017; 135: E146–E603.
   Google Scholar
• Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the american college of physicians and the american academy of family physicians. Ann Intern Med. 2017;166:430-+.
   Web of Science ®Google Scholar
• Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliché M, Milot A, et al. Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol 2016; 32: 569–588.
   Google Scholar
• Wang JW, Zhang LX, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control of hypertension in china: results from a national survey. Am J Hypertens. 2014;27:1355–61.
   PubMed Web of Science ®Google Scholar
• Huang G, Xu JB, Liu Y, Liu Z-H, Zhang Y-L, Wu Y-L, Wen R-L, Zhu S, Zhang T-J. Temporal trends in prevalence, awareness, treatment, and control of hypertension from 2000 to 2010 in Chengdu, China. Scientific Reports. 2017;7:8964.
   PubMed Web of Science ®Google Scholar
• Hu LH, Huang X, You CJ, Li JX, Hong K, Li P, Wu YQ, Wu QH, Bao HH, Cheng XS, et al. Prevalence and Risk Factors of Prehypertension and Hypertension in Southern China. PloS one 2017; 12:e0170238
   PubMed Web of Science ®Google Scholar
• Bi ZQ, Liang XF, Xu AQ, Wang LH, Shi XM, Zhao WH, Ma JX, Guo XL, Zhang XF, Zhang JY, et al. Hypertension Prevalence, Awareness, Treatment, and Control and Sodium Intake in Shandong Province, China: Baseline Results From Shandong-Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011. Prev Chronic Dis 2014; 11:e130423
   Web of Science ®Google Scholar
• Hu MQ, Wan Y, Yu LF, Yuan J, Ma YH, Hou B, Jiang X, Shang L. Prevalence, awareness, treatment, and control of hypertension and associated risk factors among adults in Xi'an, China: A cross-sectional study. Medicine 2016; 95: 34 (e4709)
   Web of Science ®Google Scholar
• Yang L, Yan J, Tang XH, Xu XL, Yu W, Wu HB. Prevalence, Awareness, Treatment, Control and Risk Factors Associated with Hypertension among Adults in Southern China, 2013. PloS one 2016; 11:e0146181
   PubMed Web of Science ®Google Scholar
• Carma A, Fang J, Yuan KM. Blood Pressure Control and Adherence to Treatment. J Clin Hypertens 2013; 15:1–1
   Web of Science ®Google Scholar
• Dastan I, Erem A, Cetinkaya V. Awareness, treatment, control of hypertension, and associated factors: results from a Turkish national study. Clin Exp Hypertens. 2018;40:90–98.
   PubMed Web of Science ®Google Scholar
• Carma A, Fang J, Yuan KM. Blood pressure control and adherence to treatment. J Clin Hypertens. 2013; 15.
   Google Scholar
• Gupta R, Pandey RM, Misra A, Agrawal A, Misra P, Dey S, Rao S, Menon VU, Kamalamma N, Vasantha Devi KP, et al. High prevalence and low awareness, treatment and control of hypertension in Asian Indian women. J Hum Hypertens. 2012;26:585–93.
   PubMed Web of Science ®Google Scholar
• Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, Prabhakaran D. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32:1170–77.
   PubMed Web of Science ®Google Scholar
• Cifkova R, Skodova Z, Bruthans J, Holub J, Adamkova V, Jozifova M, Galovcova M, Wohlfahrt P, Krajcoviechova A, Petrzilkova Z, et al. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. J Hypertens 2010; 28: 2196–2203.
   PubMed Web of Science ®Google Scholar
• Kastarinen M, Antikainen R, Peltonen M, Laatikainen T, Barengo NC, Jula A, Salomaa V, Jousilahti P, Nissinen A, Vartiainen E, et al. Prevalence, awareness and treatment of hypertension in Finland during 1982-2007. J Hypertens. 2009;27:1552–59.
   PubMed Web of Science ®Google Scholar
• Abdul-Razak S, Daher AM, Ramli AS, Ariffin F, Mazapuspavina MY, Ambigga KS, Miskan M, Abdul-Hamid H, Mat-Nasir N, Nor-Ashikin MNK, et al. Prevalence, awareness, treatment, control and socio demographic determinants of hypertension in Malaysian adults. Bmc Public Health 2016; 16:e351
   PubMed Web of Science ®Google Scholar
• Wang ZW, Wang X, Chen Z, Wang W, Zhu H, Chen W, Zhu M, Hu S, Staessen JA, Liu L, et al. hypertension control in community health centers across China: Analysis of antihypertensive drug treatment patterns. Am J Hypertens. 2014;27:252–59.
   PubMed Web of Science ®Google Scholar
• Chou WL, Wang ZJ. Regional inequality in china’s health care expenditures. Health Econ. 2009;18:S137–S146.
   PubMed Web of Science ®Google Scholar
• Khatib R, Mckee M, Shannon H, Chow C, Rangarajan S, Teo K, Wei L, Mony P, Mohan V, Gupta R, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet. 2016;387:61–69.
   PubMed Web of Science ®Google Scholar
• Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386:801–12.
   PubMed Web of Science ®Google Scholar